Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
Rebecca Simpson, Erin R. Shanahan, Marcel Batten, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2344-2352
Closed Access | Times Cited: 141

Showing 76-100 of 141 citing articles:

Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trial
Matthew S. Block, Garth D. Nelson, Jun Chen, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e011706-e011706
Open Access
Nutrition for Cancer Prevention and Therapy
Visar Vela, Besmira Sabani, Günther Spahn
(2025), pp. 209-240
Closed Access
Cutaneous immune-related adverse events to immune checkpoint inhibitors: from underlying immunological mechanisms to multi-omics prediction
Ting Cao, Xuyang Zhou, Xingbiao Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Gut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors
Juanjuan Wang, Ningning Zhu, Lei Su, et al.
Cancer Letters (2023) Vol. 582, pp. 216582-216582
Closed Access | Times Cited: 9
Harnessing human microbiomes for disease prediction
Yang Liu, Muhamad Fachrul, Michael Inouye, et al.
Trends in Microbiology (2024) Vol. 32, Iss. 7, pp. 707-719
Closed Access | Times Cited: 3
Nourishing the gut: the impact of diet on host–gut microbiota interaction
Davide Masi, Tiphaine Le Roy, Solia Adriouch, et al.
Current Opinion in Clinical Nutrition & Metabolic Care (2024) Vol. 27, Iss. 4, pp. 361-371
Closed Access | Times Cited: 3
Immune‐related adverse events of antibody‐based biological medicines in cancer therapy
Deepa Rajagopal, Elliot MacLeod, Diana Corogeanu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 13
Open Access | Times Cited: 3
Gut microbiome model predicts response to neoadjuvant immunotherapy plus chemoradiotherapy in rectal cancer
Zhengyang Yang, Jingxin Ma, Jiagang Han, et al.
Med (2024) Vol. 5, Iss. 10, pp. 1293-1306.e4
Closed Access | Times Cited: 3
Lifestyle and host determinants of antitumor immunity and cancer health disparities
Anikka M. Swaby, Aline Atallah, Ozgun Varol, et al.
Trends in cancer (2023) Vol. 9, Iss. 12, pp. 1019-1040
Open Access | Times Cited: 8
Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor
Jia Yu, Fen Xiong, Yingruo Xu, et al.
International Immunopharmacology (2023) Vol. 127, pp. 111412-111412
Closed Access | Times Cited: 8
Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2283-2296
Open Access | Times Cited: 7
An updated review of gastrointestinal toxicity induced by PD-1 inhibitors: from mechanisms to management
Yiyu Cheng, Fangmei Ling, Junrong Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Advances in psoriasis and gut microorganisms with co-metabolites
Qiushuang Zhu, Kai Wu, Qiuhong Yang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 7
Moving toward improved immune checkpoint immunotherapy for advanced prostate cancer
Marco A. De Velasco, Yurie Kura, Kazutoshi Fujita, et al.
International Journal of Urology (2024) Vol. 31, Iss. 4, pp. 307-324
Open Access | Times Cited: 2
Updates in the pathogenesis and management of immune-related enterocolitis, hepatitis and cardiovascular toxicities
Judith L. McKenzie, E. Sneath, Andrew Trinh, et al.
Immuno-Oncology Technology (2024) Vol. 21, pp. 100704-100704
Open Access | Times Cited: 2
When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms
Xi-Chen Zhao, Bo Ju, Nuan-Nuan Xiu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients
Angeli D. Macandog, Carlotta Catozzi, Mariaelena Capone, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 11, pp. 2004-2018.e9
Open Access | Times Cited: 2
The Microbiome in Advanced Melanoma: Where Are We Now?
Dylan D. Fortman, Drew Hurd, Diwakar Davar
Current Oncology Reports (2023) Vol. 25, Iss. 9, pp. 997-1016
Closed Access | Times Cited: 6
Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma
Lotte Hoeijmakers, Irene L. M. Reijers, Christian U. Blank
Cancer Discovery (2023) Vol. 13, Iss. 11, pp. 2319-2338
Closed Access | Times Cited: 6
Non-pharmaceutical interventions to optimize cancer immunotherapy
Maximilian Boesch, Florent Baty, Frank Rassouli, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 6
The Microbiome and Liver Cancer
Yuta Myojin, Tim F. Greten
The Cancer Journal (2023) Vol. 29, Iss. 2, pp. 57-60
Closed Access | Times Cited: 5
Can physiologic colonic [18F]FDG uptake in PET/CT imaging predict response to immunotherapy in metastatic melanoma?
Christos Sachpekidis, Christoph K. Stein‐Thoeringer, Annette Kopp‐Schneider, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 12, pp. 3709-3722
Open Access | Times Cited: 5
Diet-driven microbiome changes and physical activity in cancer patients
Sona Ciernikova, Aneta Sevcikova, Viola Stevurkova, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 5
Dissecting the Impact of the Gut Microbiome on Cancer Immunotherapy
Rakesh K. Jain, Andreas G. Hadjigeorgiou, Constantinos Harkos, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 5
Leveraging the microbiome in the treatment of sepsis: potential pitfalls and new perspectives
Jason J. Biemond, Braedon McDonald, Bastiaan W. Haak
Current Opinion in Critical Care (2023) Vol. 29, Iss. 2, pp. 123-129
Closed Access | Times Cited: 4

Scroll to top